VRPX (Virpax Pharmaceuticals) Total Operating Expense: $12.08 Mil (TTM As of Dec. 2024)


What is Virpax Pharmaceuticals Total Operating Expense?

Virpax Pharmaceuticals VRPX Total Operating Expense is $12.08 Mil as of Dec. 2024.

Virpax Pharmaceuticals's Total Operating Expense for the three months ended in Dec. 2024 was $3.40 Mil. Virpax Pharmaceuticals's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $12.08 Mil.

Virpax Pharmaceuticals Total Operating Expense Related Terms

Virpax Pharmaceuticals Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Virpax Pharmaceuticals's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virpax Pharmaceuticals Total Operating Expense Chart

Virpax Pharmaceuticals Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial 4.20 12.03 21.85 16.94 12.08

Virpax Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.93 3.30 3.46 1.92 3.40

Virpax Pharmaceuticals Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $12.08 Mil mean?
Virpax Pharmaceuticals (VRPX) has a Total Operating Expense of $12.08 Mil as of Dec. 2024. Total operating expense is the primary recurring expense associated with central operations. View historical data on Virpax Pharmaceuticals and its competitors.
Is Virpax Pharmaceuticals' Total Operating Expense too high?
Virpax Pharmaceuticals' current Total Operating Expense is $12.08 Mil.
How does Virpax Pharmaceuticals' Total Operating Expense compare to SYGGF and SCPX?
Virpax Pharmaceuticals' Total Operating Expense of $12.08 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Virpax Pharmaceuticals and its competitors. Virpax Pharmaceuticals's current Total Operating Expense is $12.08 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virpax Pharmaceuticals stock overvalued right now?
Virpax Pharmaceuticals (VRPX) has a current Total Operating Expense of $12.08 Mil. The current Total Operating Expense is $12.08 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Virpax Pharmaceuticals (VRPX), the current Total Operating Expense is $12.08 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Virpax Pharmaceuticals Business Description

Address 1055 Westlakes Drive, Suite 300, Berwyn, PA, USA, 19312
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.